T-knife Therapeutics
T-knife uses a mouse platform to create human TCRs for cancer treatment without modification.
78 employees · est. 2018 · San Francisco, United States
T-Therapeutics Ltd
Making T-Cell Receptor Biologics a Reality
62 employees · est. 2022 · Cambridge, United Kingdom
T-knife Therapeutics is the older company (2018 vs 2022).
Side-by-Side Comparison
| Metric | T-knife Therapeutics | T-Therapeutics Ltd |
|---|---|---|
| Founded | ||
| Founded | 2018 older | 2022 |
| Headquarters | ||
| Headquarters | San Francisco, United States | Cambridge, United Kingdom |
| Employees | ||
| Employees | 78 | 62 |
| Industry | ||
| Industry | Not tracked yet | Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Series B | Series A |
| Total Funding | ||
| Total Funding | $184.00M | $48.00M |
| Funding Rounds | ||
| Funding Rounds | 4 | 1 |
| Services | ||
| Services | Development of T Cell Therapies, Clinical Research and Trials, Biological Engineering | Development of T cell receptor-based drugs, Proprietary OpTiMus platform, Cancer treatment research and development |
| Target Customers | ||
| Target Customers | Cancer Patients with Solid Tumors, Healthcare Providers, Oncologists | Cancer patients, Healthcare professionals, Pharmaceutical companies, Investors interested in biotech |
| Taxonomy | ||
| Taxonomy | TCR-T Cell Therapy, Human TCR Development, Cancer Treatment, HuTCR Mouse Platform, Tumor-Specific TCRs, Solid Tumors, Cancer Testis Antigens, Oncoviral Antigens, Tumor-Driving Neoantigens, Adoptive T Cell Therapy, Gene Therapy, Immuno-Oncology, Tumor Immunology, TCR Generation, TCR Characterization | T-Cell Receptor Biologics, TCR Therapeutics, OpTiMus Platform, Humanized TCR Mouse, Antigen-specific TCRs, Mouse Genome Engineering, Biopharmaceutical Drug Development, Single Cell Genomics, Structural Biology, Research And Development, Therapeutic Innovation, University Spin-out, Academic Science Collaboration |
| Website | ||
| Website | t-knife.com | t-therapeutics.com |
About T-knife Therapeutics
T-knife Therapeutics is a biopharmaceutical innovator founded in 2018 in the United States. The company is at the forefront of developing transformative therapies to combat cancer through its proprietary technology. Central to its mission is a paradigm-shifting approach utilizing its HuTCR mouse pla...
About T-Therapeutics Ltd
T-Therapeutics Ltd, with the slogan "Making T-Cell Receptor Biologics a Reality", is a promising startup in the Biotechnology and Health Care sectors, headquartered in the United Kingdom. Founded in 2022 as a spin-out from the University of Cambridge, it rides on the waves of cutting-edge academic s...
We will tell you when either one moves
BounceWatch watches T-knife Therapeutics and T-Therapeutics Ltd for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at T-knife Therapeutics and T-Therapeutics Ltd — by email.
Frequently Asked Questions
Compare T-knife Therapeutics with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at T-knife Therapeutics on 15 Jun 2026, and T-Therapeutics Ltd on 25 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.